Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Formative Research (no longer under consideration since May 19, 2026)

Date Submitted: Nov 10, 2024
Open Peer Review Period: Dec 25, 2024 - Feb 19, 2025
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Exploration of the Feasibility of a Mobile-based Combined Exercise Intervention Application(Rebone) for the Management of Menopausal Symptoms

  • Hyuntak Lee; 
  • Hyunmin Kang; 
  • Chaieun Park; 
  • Minina Ju; 
  • Changguen Oh; 
  • Justin Y Jeon; 
  • Seokko Seo; 
  • Jinwoo Kim; 
  • Jeehang Lee

ABSTRACT

Background:

Medical, mental, and social challenges associated with menopause are significant in the field of women’s health. Exercise therapy can serve as an alternative treatment for alleviating menopausal symptoms, and it is crucial to engage in regular physical activity to experience its benefits. Mobile-based exercise applications can help establish exercise habits and provide guidance on workouts. Given that menopause is experienced by all women, mobile health (mHealth) services may have great social value. Furthermore, the various changes that begin after menopause increase the risk of chronic diseases. Thus, prevention and treatment can reduce the demand for medical care and lower overall medical costs.

Objective:

This study aimed to design and implement a mobile application (app), Rebone, specifically for menopausal women. It also sought to determine the initial feasibility of a combined exercise program, consisting of aerobic exercise and resistance exercise, provided by the app to alleviate menopausal symptoms.

Methods:

During April 2022, we collected data related to menopausal symptoms, quality of life, depression, insomnia, and stress from 33 individuals with similar characteristics (age, gender, height, weight). Subsequently, we compared the data collected before and after implementing an eight-week, mixed exercise program consisting of aerobic and resistance exercises, provided via a mobile app, conducted at least three times a week.

Results:

An independent sample t-test was performed after the normality test to compare the differences between the two groups pre- and post-program. After eight weeks, MRS (p = 0.002), MENQOL (p = 0.002), CES-D (p = 0.001), SRI (p = 0.027), and ISI (p = 0.000) all showed statistically significant differences between the two groups. In addition, the treatment group exercised more frequently and performed more appropriate workouts than the control group.

Conclusions:

Statistically significant differences between the two groups were found for all collected data after the intervention. Furthermore, the frequency of exercise by group and qualitative feedback from participants indicate that mobile-based interventions for menopausal women are effective. Clinical Trial: This study was approved by the Basic Science Research Program through the ICONS (Institute of Convergence Science), Yonsei University Science and Technology, and the National Research Foundation of Korea (NRF). It was also approved by Yonsei University’s Industry-Academic Cooperation Group's In-School Research Promotion Project (2022YSRESEARCH) and was funded by the Ministry of Education (NRF-2016R1D1A1B02015987). Lastly, this research was supported by a grant of the Information and Communications Promotion Fund through the National IT Industry Promotion Agency (NIPA), funded by the Ministry of Science and ICT (MSIT), Republic of Korea.


 Citation

Please cite as:

Lee H, Kang H, Park C, Ju M, Oh C, Jeon JY, Seo S, Kim J, Lee J

Exploration of the Feasibility of a Mobile-based Combined Exercise Intervention Application(Rebone) for the Management of Menopausal Symptoms

JMIR Preprints. 10/11/2024:68596

DOI: 10.2196/preprints.68596

URL: https://preprints.jmir.org/preprint/68596

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.